WSPOS 2025 Consensus Statement
June 11, 2025

WSPOS Myopia Consensus Statement 2025: What Parents and Practitioners Need to Know

Myopia, or nearsightedness, has become one of the most pressing pediatric health issues of our time. What used to be…

Alcon TRYPTYR FDA approval
May 29, 2025

Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease 

TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland)  has…

Discover our fascinating content at issuu

explore